Country: United States
Language: English
Source: NLM (National Library of Medicine)
VERAPAMIL HYDROCHLORIDE (UNII: V3888OEY5R) (VERAPAMIL - UNII:CJ0O37KU29)
Cadila Pharmaceuticals Limited
VERAPAMIL HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE 180 mg
ORAL
PRESCRIPTION DRUG
Verapamil hydrochloride extended-release tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacolog
Verapamil hydrochloride extended-release tablets, USP 120 mg are supplied as light blue, oval shaped, film coated tablets debossed with “V12” on one side and plain on other side. NDC Number Size NDC 71209-104-05 bottle of 100 NDC 71209-104-10 bottle of 500 Verapamil hydrochloride extended-release tablets, USP 180 mg are supplied as light blue, oval shaped, scored, film coated tablets debossed with C 75 on one side and plain on other side. NDC Number Size NDC 71209-047-05 bottle of 100 NDC 71209-047-40 bottle of 500 Verapamil hydrochloride extended-release tablets, USP 240 mg are supplied as light blue, capsule shaped, bevelled edged, scored, film coated tablets debossed with C 77 on one side and plain on other side. NDC Number Size NDC 71209-048-05 bottle of 100 NDC 71209-048-10 bottle of 500 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature] and protect from light and moisture. Dispense in tight, light-resistant containers. Manufactured by: Cadila Pharmaceuticals Limited 1389, Dholka, District - Ahmedabad, Gujarat State, INDIA Revised May, 2022
Abbreviated New Drug Application
VERAPAMIL HYDROCHLORIDE - VERAPAMIL HYDROCHLORIDE TABLET, EXTENDED RELEASE CADILA PHARMACEUTICALS LIMITED ---------- DESCRIPTION Verapamil hydrochloride extended-release tablets, USP is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist). Verapamil hydrochloride extended- release tablets, USP is available for oral administration as light blue, capsule shaped, bevelled edged, scored, film coated tablets containing 240 mg of verapamil hydrochloride USP; as light blue, oval shaped, scored, film coated tablets containing 180 mg of verapamil hydrochloride USP; and light blue, oval shaped, film coated tablets containing 120 mg of verapamil hydrochloride USP (equivalent to 111.08 mg verapamil free base). The tablets are designed for sustained-release of the drug in the gastrointestinal tract; sustained-release characteristics are not altered when the tablet is divided in half. The structural formula of verapamil HCl USP is: BENZENEACETONITRILE, Α-[3-[[2-(3,4- DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-Α-(1- METHYLETHYL)HYDROCHLORIDE Verapamil HCl, USP is an almost white, crystalline powder, practically free of odor, with a bitter taste. It is soluble in water, chloroform, and methanol. Verapamil HCl, USP is not chemically related to other cardioactive drugs. Inactive ingredients include colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, sodium alginate, and film coating contains FD&C Blue No. 1 Brilliant Blue FCF aluminum lake, hypromellose, iron oxide yellow, titanium dioxide and triacetin. Verapamil hydrochloride extended-release tablets USP, 120 mg, 180 mg and 240 mg meet USP Dissolution Test 3. CLINICAL PHARMACOLOGY Verapamil HCl is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) that exerts its pharmacologic effects by modulating the influx of ionic calcium across the cell membrane of the arterial smooth muscle as well as in conductile and contractile myocardial Read the complete document